- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-005641-21. Displaying page 1 of 1.
|EudraCT Number: 2012-005641-21||Sponsor Protocol Number: 112148||Start Date*: 2015-05-26|
|Sponsor Name:GlaxoSmithKline Biologicals|
|Full Title: A phase III, open, controlled study to assess the persistence of antibodies after one dose of GlaxoSmithKline Biologicals’ meningococcal serogroup ACWY conjugate vaccine (MenACWY-TT) given intramus...|
|Medical condition: Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and/or Y|
|Population Age: Adolescents, Under 18, Adults||Gender: Male, Female|
|Trial protocol: Outside EU/EEA|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.